Nomura Holdings’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,842,562
Closed -$233M 1520
2018
Q3
$233M Buy
1,842,562
+2,833
+0.2% +$424K 0.82% 16
2018
Q2
$293M Sell
1,839,729
-4,359
-0.2% -$646K 0.93% 17
2018
Q1
$264M Sell
1,844,088
-208,000
-10% -$28.4M 0.45% 26
2017
Q4
$273M Sell
2,052,088
-68,925
-3% -$8.81M 0.49% 25
2017
Q3
$264M Sell
2,121,013
-152,343
-7% -$21M 0.55% 27
2017
Q2
$319M Buy
2,273,356
+2,266,144
+31,422% +$283M 0.78% 13
2017
Q1
$812K Buy
7,212
+4,605
+177% +$537K ﹤0.01% 810
2016
Q4
$271K Buy
+2,607
New +$280K ﹤0.01% 1371
2016
Q1
Sell
-1,551
Closed -$250K 2201
2015
Q4
$250K Buy
+1,551
New +$240K ﹤0.01% 1443
2015
Q2
Sell
-2,694
Closed -$324K 2168
2015
Q1
$324K Buy
+2,694
New +$359K ﹤0.01% 1291
2014
Q3
Sell
-12,600
Closed -$1.58M 3186
2014
Q2
$1.58M Buy
+12,600
New +$1.63M ﹤0.01% 1246
2014
Q1
Sell
-1,691
Closed -$226K 3011
2013
Q4
$226K Sell
1,691
-2,487
-60% -$320K ﹤0.01% 1696
2013
Q3
$454K Sell
4,178
-2,287
-35% -$247K ﹤0.01% 1437
2013
Q2
$548K Buy
+6,465
New +$579K ﹤0.01% 1264

Other funds holding ATHN

Nomura Holdings's ATHN Position: Q4 2018 in Review

Nomura Holdings sold out of Athenahealth, Inc. (ATHN) in Q4 2018, closing a stake of 1,842,562 shares — an estimated $233M sold.

Nomura Holdings first reported a position in ATHN in Q2 2013 and held it in 14 quarters. The position peaked at $319M in Q2 2017. 263 funds tracked by Wall St. Rank hold ATHN as of Q4 2018.

  • Nomura Holdings reported no remaining Athenahealth, Inc. position as of Q4 2018 after selling out during the quarter.
  • Nomura Holdings sold 1,842,562 Athenahealth, Inc. shares in Q4 2018, an estimated $233M.
  • Nomura Holdings first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 14 quarters.
  • Nomura Holdings's Athenahealth, Inc. position peaked at $319M in Q2 2017.
  • 263 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2018.

Based on Nomura Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.